Goffe v. Pharmaseal Laboratories, Inc.

568 P.2d 600, 90 N.M. 764
CourtNew Mexico Court of Appeals
DecidedDecember 7, 1976
Docket2480
StatusPublished
Cited by15 cases

This text of 568 P.2d 600 (Goffe v. Pharmaseal Laboratories, Inc.) is published on Counsel Stack Legal Research, covering New Mexico Court of Appeals primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Goffe v. Pharmaseal Laboratories, Inc., 568 P.2d 600, 90 N.M. 764 (N.M. Ct. App. 1976).

Opinions

OPINION

HERNANDEZ, Judge.

Plaintiff appeals the granting of a summary judgment in favor of the defendants.

On August 26, 1971, plaintiff entered the defendant Presbyterian Hospital (Hospital) suffering from an intestinal obstruction. He was treated by defendant Dr. J. Hunt Burress. The treatment consisted of inserting a K-2R Kaslow intestinal tube, manufactured by defendant Pharmaseal Laboratories, Inc. (Laboratory), through his nose, and thence through the stomach into the intestine. To help in inserting the tube into the intestine, it was weighted with a small rubber balloon tied to the end of the tube and containing metallic mercury, also called quicksilver. The tube, balloon and quicksilver were purchased from the Hospital. Dr. Burress put the mercury into the balloon and tied it onto the end of the tube. On the morning of August 30, 1971, the intestinal obstruction having been removed, Dr. Burress started to withdraw the tube. While he was in the process of removing the tube, the balloon containing the mercury broke as the bag started to enter the nasal passage. As a consequence, the plaintiff inhaled some of the mercury into his lungs. Dr. Burress, with the help of some of the hospital staff, turned the plaintiff upside down and pounded him on the back to cause him to cough up the mercury. How much he inhaled is not known and how much stayed in his system is not known. There is nothing in the record to indicate that the mercury being in his system had any adverse effects. The tube and the balloon were disposed of and no one had the opportunity to examine them. On the day following these events the plaintiff suffered a myocardial infarction.

Plaintiff in his complaint alleged that Dr. Burress “did not exercise the degree of care or skill ordinarily exercised by others of his profession in similar treatment in that he removed said tube in a hasty, negligent, and unskilled manner, resulting in the rupture of a bag of mercury . . .” He further alleged that Dr. Burress directed others to pound him on the back to remove the mercury and this “pounding resulted in a coronary thrombosis with a subsequent myocardial infarction.” As to the Laboratory, the plaintiff alleged that the “tube was in a defective condition unreasonably dangerous to a user or patient in that the bag of mercury attached to the tube in the treatment is improperly designed and unsafe to persons undergoing treatment . .” Also, that the tube “was not of a merchantable quality nor was it fit for the purpose for which it was intended.” That the Laboratory had “breached an implied warranty of merchantibility and fitness . .” In regard to the Hospital, the plaintiff alleged that Dr. Burress was its agent or employee and that in doing the various things he did he was acting within the scope of his employment.

The plaintiff alleges four points of error. We will discuss together points 1, 3 and 4, which are as follows:

“POINT I
“SUMMARY JUDGMENT WAS IMPROPER-ISSUES OF FACT FOR THE JURY TO DECIDE EXISTED. ******
“POINT III
“EVEN IF DEFENDANTS ESTABLISHED THE LACK OF MATERIAL ISSUES, PLAINTIFF MET HIS BURDEN OF COMING FORTH WITH TANGIBLE EVIDENCE DEMONSTRATING THAT THERE EXISTS A TRIABLE ISSUE OF FACT, PRECLUDING SUMMARY JUDGMENT.
“POINT IV
“EVEN IF THE STRICT LOCALITY RULE HAS NOT BEEN SATISFIED, THE STANDARD TO BE USED IS A NATIONAL ONE, NOT LOCAL.”

Section 21-l-l(56)(c), N.M.S.A. 1953 (Repl. Vol. 4) provides in pertinent part that: “The [summary] judgment sought shall be rendered forthwith if the pleadings, depositions, answers to interrogatories, and admissions on file, together with the affidavits, if any, show that there is no genuine issue as to any material fact and that the moving party is entitled to a judgment as a matter of law.” Our Supreme Court in Goodman v. Brock, 83 N.M. 789, 498 P.2d 676 (1972) adopted the following language from 3 Barron & Holtzoff, Federal Practice and Procedure, § 1234 at 124-126 (rev’d Wright 1958) as the rule to be applied in determining whether a motion for summary judgment should be granted or not:

“ . . the party opposing the motion is to be given the benefit of all reasonable doubts in determining whether a genuine issue exists. If there are such reasonable doubts, summary judgment should be denied. A substantial dispute as to a material fact forecloses summary judgment.”

The Supreme Court went on to say that once the moving party has made a prima facie showing that he is entitled to summary judgment, the burden shifts to the opposing party to show that there is a genuine factual issue. “By a prima facie showing is meant such evidence as is sufficient in law to raise a presumption of fact or establish the fact in question unless rebutted. . The inferences, which the party opposing the motion for summary judgment is entitled to have drawn from all the matters properly before and considered by the trial court, must be reasonable inferences.” [Emphasis ours.] The rules governing consideration of medical malpractice cases are set forth in Cervantes v. Forbis, 73 N.M. 445, 389 P.2d 210 (1964):

“Before a physician or surgeon can be held liable for malpractice in the treatment of his patient, he must have departed from the recognized standards of medical practice in the community, or must have neglected to do something required by those standards. [Citations omitted.] The fact that a poor result is achieved or that an unintended incident transpired, unless exceptional circumstances are present, does not establish liability without a showing that the result or incident occurred because of the physician’s failure to meet the standard either by his acts, neglect, or inattention. Such facts must generally be established by expert testimony. [Citations omitted.] Likewise, expert testimony is generally required to establish causal connection.”

Furthermore, the medical expert or experts must be qualified to express an opinion concerning the recognized standard of medical practice in the community and an opinion that the defendant departed from that standard or neglected to do something required by the standards. Gandara v. Wilson, 85 N.M. 161, 509 P.2d 1356 (Ct. App. 1973).

At the outset of our discussion, it is well to remind ourselves that a medical malpractice suit is a negligence action. The elements necessary to such a cause of action are:

“1. A duty, or obligation, recognized by the law, requiring the actor to conform to a certain standard of conduct, for the protection of others against unreasonable risks.
“2. A failure on his part to conform to the standard required. These two elements go to make up what the courts usually have called negligence; but the term quite frequently is applied to the second alone. Thus it may be said that the defendant was negligent, but is not liable because he was under no duty to the plaintiff not to be.
“3.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Leger v. Gerety
444 P.3d 1036 (New Mexico Court of Appeals, 2018)
Alberts v. Schultz
975 P.2d 1279 (New Mexico Supreme Court, 1999)
Trull v. Long
621 So. 2d 1278 (Supreme Court of Alabama, 1993)
Deer Mesa Corp. v. Los Tres Valles Special Zoning District Commission
712 P.2d 21 (New Mexico Court of Appeals, 1985)
Hall v. Hilbun
466 So. 2d 856 (Mississippi Supreme Court, 1985)
Henning v. Parsons
623 P.2d 574 (New Mexico Court of Appeals, 1981)
Cooper v. Curry
589 P.2d 201 (New Mexico Court of Appeals, 1979)
Pharmaseal Laboratories, Inc. v. Goffe
568 P.2d 589 (New Mexico Supreme Court, 1977)
Goffe v. Pharmaseal Laboratories, Inc.
568 P.2d 600 (New Mexico Court of Appeals, 1976)

Cite This Page — Counsel Stack

Bluebook (online)
568 P.2d 600, 90 N.M. 764, Counsel Stack Legal Research, https://law.counselstack.com/opinion/goffe-v-pharmaseal-laboratories-inc-nmctapp-1976.